Coordinating Minister for the National COVID-19 Immunisation Programme Khairy Jamaluddin recently announced that there is not enough data for Malaysia to consider mixing two different COVID-19 vaccines. What do current studies on mixing vaccines show, and what kind of data would help Malaysian authorities to make an evidence-based decision? We find out more from Dr Vinod Balasubramaniam, molecular virologist, who also weighs in on how we should address concerns among those who are vaccine hesitant.

Image source: Shutterstock 

Produced by: Tee Shiao Eek, Janese Wong

Presented by: Meera Sivasothy

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Business Analysis,  Trends and Forecasts,  Markets,  Politics,  Social Issues,  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology,  law & legal matters,  Science,  Investments,  Personal Finance,  Financial Literacy,  Young Finance,  Property,  SME,  Entrpreneurship,  Education

Tags:  The Bigger Picture,  Health & Living,  COVID-19,  vaccine,  AstraZeneca,  Pfizer,  Sinovac,  immunisation,